A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine-Reference-Cited by-同舟云学术

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

Published:2004-08 Issue:23-24 Volume:22 Page:3004-3007
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ault Kevin A,Giuliano Anna R,Edwards Robert P,Tamms Gretchen,Kim Lee-Lian,Smith Judith F,Jansen Kathrin U,Allende Maria,Taddeo Frank J,Skulsky DeeMarie,Barr Eliav

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference10 articles.

1. Epidemiology of genital human papillomavirus infection;Koutsky;Am. J. Med.,1997

2. Human papilloma virus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix;Madeleine;Cancer Epidemiol. Biomarkers Prev.,2001

3. Cervical cancer in Canada: changing patterns in incidence and mortality;Liu;Int. J. Gynecol. Cancer,2001

4. A phase I study of a recombinant virus-like particle against human papilloma virus type 11 in healthy adult volunteers;Evans;J. Infect. Dis.,2001

5. A controlled trial of a human papillomavirus type 16 vaccine;Koutsky;N. Engl. J. Med.,2002

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing atomic force microscopy images of virus-like particles by expectation-maximization;npj Vaccines;2024-06-20

2. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma;Current Problems in Cancer;2021-12

3. Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial;BMC Public Health;2020-02-27

4. HPV Vaccine: Updates and Highlights;Acta Cytologica;2019

5. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors;Cochrane Database of Systematic Reviews;2018-05-09